Meanwhile, subcutaneous injection segment experiences the fastest growth because recent label expansions for weight management indications have intensified demand among patients seeking higher efficacy
Ozempic, a once-weekly GLP-1 receptor agonist, has not been approved by the FDA specifically for weight loss on its own label
The fact that they worked was serendipity, Randy Seeley, an obesity researcher at the University of Michigan, told me
This guide breaks down everything that separates these two peptides, from their molecular mechanisms to their real-world results, so you can make a decision based on evidence rather than hype
Ratio Improvement: Despite absolute muscle loss, the STEP 1 trial showed that the proportion of lean mass relative to total body weight actually increased